Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapeutic application for the aged with CML].

M Ohta1

  • 1Department of Hematology, Tokyo Metropolitan Geriatric Medical Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural elucidation of a novel phosphonoglycosphingolipid in eggs of the sea hare Aplysia juliana.

Biochimica et biophysica acta·1992
Same author

Crosslinking of proteins in acetylcholine receptor-rich membranes from Torpedo californica: relation of 43-kD protein and Torpedo dystrophin to acetylcholine receptor.

Biochemistry international·1992
Same author

Analysis of growth failure in children treated for acute lymphoblastic leukemia.

International journal of hematology·1992
Same author

Splenic hyperkinetic state and splenic artery aneurysm in portal hypertension.

Hepato-gastroenterology·1992
Same author

In vitro proliferation and the cytotoxic specificity of a cryopreserved cytotoxic T cell clone reacting against human autologous tumor cells.

Journal of immunological methods·1992
Same author

Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.

Experimental hematology·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Interferon-alpha therapy is now the preferred treatment for elderly chronic myeloid leukemia (CML) patients, improving survival and response rates. Careful monitoring for side effects like psychological changes is essential during CML treatment.

Area of Science:

  • Hematology
  • Oncology
  • Geriatric Medicine

Context:

  • Elderly patients with chronic myeloid leukemia (CML) previously had limited therapeutic options, often restricted to alkylating or antimetabolite agents.
  • Improving the quality of life for aged CML patients is a significant clinical challenge.

Purpose:

  • To evaluate interferon-alpha as a first-choice therapy for elderly patients with chronic phase CML.
  • To assess the efficacy and safety of interferon-alpha in this demographic.

Summary:

  • Interferon-alpha therapy is now the first choice for treating elderly patients with chronic phase CML, offering improved quality of life.
  • This treatment has demonstrated long-term survival benefits, including cytological and cytogenetic responses, even in the aged population.
  • Psychological side effects require careful attention in elderly CML patients undergoing interferon-alpha therapy.

Related Experiment Videos

Impact:

  • Interferon-alpha therapy enhances long-term survival and treatment response in elderly CML patients.
  • Highlights the need for vigilant monitoring of potential adverse effects, particularly psychological changes.
  • Paves the way for ongoing research into molecularly targeted therapies and stem cell transplantation for CML in the elderly.